Finance

Beta
Lists
6990:HKG
Sichuan Kelun-Biotech Biophrmctcl Co Ltd
HK$382.00
-2.90%
(-11.40) 1D
Jun 8, 4:09:01 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 6990...
Open
HK$393.40
High
HK$393.40
Low
HK$377.00
Mkt. cap
89.08B
Avg. vol.
785.46K
Volume
844.08K
52-wk high
HK$581.00
52-wk low
HK$314.20
EPS
-HK$1.92
Shares outstanding
170.98M
No. of employees
2K
Open
HK$393.40
High
HK$393.40
Low
HK$377.00
Mkt. cap
89.08B
Avg. vol.
785.46K
Volume
844.08K
52-wk high
HK$581.00
52-wk low
HK$314.20
EPS
-HK$1.92
Shares outstanding
170.98M
No. of employees
2K
Analyst outlook
Analyst Ratings
Based on 12 analysts giving stock ratings to 6990 in the past 3 months
Strong Buy
Buy
12
Hold
0
Sell
0
12 month forecast
Based on 12 Wall Street analysts offering 12 month price targets for 6990 in the last 3 months.
Highest
Current HK$382.00
HK$625.00 (+63.61%)
Average
HK$548.99 (+43.71%)
Lowest
HK$507.11 (+32.75%)
News stories
From sources across the web
About Sichuan Kelun-Biotech Biophrmctcl Co Ltd
CEO-
Employees2.04K
Founded2016
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
475.22M
475.22M
553.74M
553.74M
Cost of goods sold
145.23M
145.23M
144.34M
144.34M
Cost of revenue
145.23M
145.23M
144.34M
144.34M
Research and development expenses
305.77M
305.77M
354.07M
354.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
126.38M
126.38M
200.60M
200.60M
Operating expense
428.29M
428.29M
520.88M
520.88M
Total operating expenses
573.52M
573.52M
665.23M
665.23M
Operating income
-98.30M
-98.30M
-111.49M
-111.49M
Other non operating income
-
-
-
-
EBT including unusual items
-87.78M
-87.78M
-90.11M
-90.11M
EBT excluding unusual items
-94.28M
-94.28M
-109.96M
-109.96M
Income tax expense
-15.19M
-15.19M
28.29M
28.29M
Effective tax rate
17.31%
17.31%
-31.39%
-31.39%
Other operating expenses
-3.86M
-3.86M
-33.78M
-33.78M
Net income
-72.59M
-72.59M
-118.40M
-118.40M
Net profit margin
-15.27%
-15.27%
-21.38%
-21.38%
Earnings per share
-
-
-
-
Interest and investment income
6.35M
6.35M
25.42M
25.42M
Interest expense
-1.51M
-1.51M
-1.57M
-1.57M
Net interest expenses
4.84M
4.84M
23.85M
23.85M
Depreciation and amortization charges
-
-
-
-
EBITDA
-85.11M
-85.11M
-97.28M
-97.28M
Gain or loss from assets sale
-
-
61.50K
61.50K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more